ADT 2006 Annual Report Download - page 69

Imaging
The Imaging Division is devoted to improving the diagnostic sciences of X-ray, magnetic resonance
imaging (MRI) and nuclear medicine. By developing, manufacturing, and marketing contrast agents,
radiopharmaceuticals and delivery systems, Mallinckrodt Imaging helps enhance the utility and quality
of images obtained via these procedures. Mallinckrodt’s Imaging Division partners with radiologists,
cardiologists and nuclear medicine physicians to improve the quality of diagnosis in multiple disease
states through well known branded diagnostic pharmaceuticals, including OPTIRAY X-ray contrast
media, OPTIMARK MRI contrast media, thallium, technetium, TECHNESCAN MAG3
radiopharmaceutical and NeutroSpec. The MALLINCKRODT family of imaging products is sold into
hospitals, radiopharmacies and alternate site imaging centers throughout the world.
International
The International Division is responsible for the marketing, distribution and export of all Tyco
Healthcare Group products (excluding Pharmaceuticals and Retail products) outside of the United
States. The International Division markets directly to hospitals and medical professionals, as well as
through independent distributors with a worldwide presence. Although the mix of product lines offered
varies from country to country, its operations are organized primarily into four geographic regions:
Europe/Middle East/Africa, Japan, the Asia-Pacific region and Latin America.
Pharmaceuticals
The Mallinckrodt Pharmaceutical Division is comprised of three businesses—Bulk Pharmaceuticals
(active pharmaceutical ingredients), Dosage Pharmaceuticals and Specialty Chemicals. The Bulk
Pharmaceuticals business is the largest producer of both medicinal narcotics and acetaminophen
worldwide. Ninety-five percent of these products are used within the pharmaceutical industry to
manufacture dosage form drugs. The Dosage Pharmaceuticals business has four distinct divisions:
generic narcotic pharmaceuticals, branded central nervous systems products, addiction treatment
products and contract pharmaceutical manufacturing for third parties. These products are sold to major
wholesalers and drug store chains primarily in the United States. The Specialty Chemicals business
includes a wide array of specialty chemicals targeted at research and development and analytical
laboratories; process materials used to manufacture biopharmaceuticals; and specialty chemicals used to
manufacture semiconductor chips, many of which are sold under the J.T. BAKER name in the United
States.
Retail
The Retail Division is the industry leader for retail brand adult incontinent care, infant care and
feminine hygiene products within continental North America. This division develops, manufactures and
markets a wide variety of retail brand products for the North American retail markets supplying a
broad majority of retail mass merchandisers, food stores and drug stores. Through our ‘‘first-to-market’’
approach, the Retail Division helps retailers such as Wal-Mart, Target, Kroger, Albertson’s, CVS,
Loblaw, Dollar General and Family Dollar manage their categories and build their own store brand
presence with the high-quality products consumers demand.
Tyco Healthcare’s competitors include Johnson & Johnson, Becton Dickinson and C.R. Bard,
among others, and competition is based on breadth of product offerings, quality of product, service and
price.
IV. Engineered Products and Services
Tyco is the world’s leading manufacturer of industrial valves and controls. With 2006 net revenue
of $7.0 billion, our Engineered Products and Services businesses comprise 17% of our consolidated net
2006 Financials 7